Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed the day trading at $16.09 down -7.79% from the previous closing price of $17.45. In other words, the price has decreased by -$7.79 from its previous closing price. On the day, 1.86 million shares were traded. SPRY stock price reached its highest trading level at $17.38 during the session, while it also had its lowest trading level at $16.01.
Ratios:
For a better understanding of SPRY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.74 and its Current Ratio is at 11.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $30.
On February 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 27 ’25 when Flynn James E sold 740,149 shares for $18.46 per share. The transaction valued at 13,663,151 led to the insider holds 4,887,254 shares of the business.
ERIC KARAS bought 15,000 shares of SPRY for $254,859 on Jul 01 ’25. On Jun 18 ’25, another insider, Karas Eric, who serves as the Chief Commercial Officer of the company, sold 15,000 shares for $16.00 each. As a result, the insider received 240,000 and left with 7,696 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1580256896 and an Enterprise Value of 1507555584. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.27 while its Price-to-Book (P/B) ratio in mrq is 6.90. Its current Enterprise Value per Revenue stands at 15.522 whereas that against EBITDA is -56.42.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.89, which has changed by 0.770077 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.90, while it has fallen to a 52-week low of $8.35. The 50-Day Moving Average of the stock is 9.62%, while the 200-Day Moving Average is calculated to be 18.76%.
Shares Statistics:
Over the past 3-months, SPRY traded about 1.56M shares per day on average, while over the past 10 days, SPRY traded about 2053210 shares per day. A total of 98.13M shares are outstanding, with a floating share count of 54.77M. Insiders hold about 44.24% of the company’s shares, while institutions hold 53.66% stake in the company. Shares short for SPRY as of 1749772800 were 16577058 with a Short Ratio of 10.65, compared to 1747267200 on 18230628. Therefore, it implies a Short% of Shares Outstanding of 16577058 and a Short% of Float of 27.61.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
